2022
Botulinum Toxin Treatment of Pain Disorders
Jabbari B. Botulinum Toxin Treatment of Pain Disorders. 2022 DOI: 10.1007/978-3-030-99650-5.Peer-Reviewed Original ResearchBotulinum toxin treatmentPain disordersToxin treatmentPost-traumatic neuralgiaPain medicine specialistsEvidence-based literature reviewLow back painPain syndromeAnalgesic effectPain categoriesPlantar fasciitisBack painBoNT therapyTreatment menuIllustrative case historiesMedicine specialistsAnimal studiesPainDisordersTreatmentClinical chaptersLiterature reviewFasciitisNeuralgiaInternists
2018
Botulinum toxin treatment of pain syndromes –an evidence based review
Safarpour Y, Jabbari B. Botulinum toxin treatment of pain syndromes –an evidence based review. Toxicon 2018, 147: 120-128. PMID: 29409817, DOI: 10.1016/j.toxicon.2018.01.017.Peer-Reviewed Original ResearchConceptsLevel B evidencePain syndromeLevel of evidencePelvic painB evidenceMale pelvic pain syndromeChronic low back painTraumatic spinal cord injuryEfficacy of BoNTFemale pelvic painMale pelvic painVastus lateralis imbalanceMyofascial pain syndromePelvic pain syndromePost-herpetic neuralgiaAnterior knee painBotulinum toxin treatmentPainful knee osteoarthritisPost-operative painDifferent pain syndromesLow back painSpinal cord injuryCarpal tunnel syndromeTotal knee arthroplastyRole of BoNT
2016
Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain
Machado D, Kumar A, Jabbari B. Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain. Toxins 2016, 8: 374. PMID: 27983689, PMCID: PMC5198568, DOI: 10.3390/toxins8120374.Peer-Reviewed Original ResearchConceptsChronic low back painLow back painVisual analog scaleOswestry Low Back Pain Disability QuestionnaireAbobotulinum toxin ABack painQuality of lifeToxin APain Disability QuestionnairePatient Global ImpressionLevel of painPrimary outcome measureProportion of respondersStrong analgesic effectAbobotulinum toxinOswestry scorePlacebo groupAnalgesic effectDisability QuestionnaireMore patientsStudy cohortAnalog scaleGlobal ImpressionMultifactorial pathophysiologyPatients' perceptions
2011
Treatment of Refractory Pain with Botulinum Toxins—An Evidence-Based Review
Jabbari B, Machado D. Treatment of Refractory Pain with Botulinum Toxins—An Evidence-Based Review. Pain Medicine 2011, 12: 1594-1606. PMID: 21958302, DOI: 10.1111/j.1526-4637.2011.01245.x.Peer-Reviewed Original ResearchConceptsPost-operative painRefractory painBotulinum toxinChronic low back painChronic lateral epicondylitisClass II articlesLevel B evidenceLevel C evidencePost-traumatic neuralgiaVastus lateralis imbalanceMyofascial pain syndromePlacebo-controlled studyPost-herpetic neuralgiaAnterior knee painPainful knee osteoarthritisChronic daily headacheLow back painTotal knee arthroplastyEvidence-based reviewEvidence-based dataSphincter spasmKnee painPain syndromePelvic painPiriformis syndrome
2007
Treatment of chronic low back pain with botulinum neurotoxins
Jabbari B. Treatment of chronic low back pain with botulinum neurotoxins. Current Pain And Headache Reports 2007, 11: 352-358. PMID: 17894925, DOI: 10.1007/s11916-007-0217-1.Peer-Reviewed Original ResearchConceptsLow back painChronic low back painBack painParaspinal musclesRefractory chronic low back painRefractory low back painFlu-like reactionsSignificant pain reliefOpen-label studyPlacebo-controlled studyBotulinum toxin ALumbar erector spinaeBotulinum treatmentPain reliefTechniques of treatmentLumbar levelsToxin AErector spinaePainSide effectsTrigger pointsInjection siteTotal dosePatientsEarly response